Orcoda Explodes Higher as Tech Week Splits on Contracts, Cash and Court Risk

Orcoda (ASX:ODA) was the clear standout, jumping 179.07% after it won a multi-year Wellcamp contract worth about $8 million a year. Investors cared because this was not a concept story. It was a named customer, a start date and a large revenue number. At the other end, ClearVue Technologies (ASX:CPV) sank 40.00% even as it raised fresh cash and advanced product certification. Credit Clear (ASX:CCR) lost 28.57% after the ACCC alleged unlawful debt collection conduct by two subsidiaries. That legal fight matters because it can take time, cost money and distract management.

Contracts beat concepts

Several of the week’s stronger updates came from companies that could point to signed deals. Vection Technologies (ASX:VR1) secured about $2.3 million in new AI contracts across five sectors, taking orders since April to about $7 million. The stock still finished down for the week, which suggests early buying faded as traders banked gains or worried that small contracts across many sectors may take time to turn into steady profit. Acusensus (ASX:ACE) added a six-month NSW contract extension worth about $16 million. Etherstack (ASX:ESK) won a US$0.83 million follow-on order in North America. Vista Group (ASX:VGL) also added a large European cinema software deal. These updates were easier for investors to price because they involved customers, terms and expected revenue timing.

AI stayed busy, but buyers were selective

Nanoveu (ASX:NVU) delivered two strong technical updates. One showed always-on voice functions running together on very low power. The other showed better drone energy use in live tests. In plain English, the chip appeared to do useful AI work while using very little battery. Even so, the shares fell for the week after reopening lower. That tells you investors wanted more than lab and trial results. They likely wanted clearer signs of near-term sales. Activeport (ASX:ATV) also slipped after launching an AI Gateway with FirstWave. The offer gives big customers secure access to graphics processors, which are the chips used to run AI workloads. Again, the idea was well received on paper, but the share price suggested concern about how fast revenue will arrive. Pathkey.AI (ASX:PKY) was one of the cleaner AI winners, climbing 18.33% after completing its Chipforge acquisition. Investors backed the deal because it moved the company into semiconductor design software, which is a bigger and broader commercial field than its earlier clinical trial focus. FortifAI (ASX:FTI) also rose after outlining the size of the agentic AI infrastructure market and then adding senior technology names to its advisory board. Asset Vision (ASX:ASV) gained on a 45% lift in annual recurring revenue run rate. That figure means the business is now running at a higher yearly pace from repeating software income.

Fresh cash helped some companies and hurt others

Capital raising news was everywhere. ClearVue raised its funding target to $6.25 million and secured product certification for its Gen 3 glass, yet the shares still fell heavily. Investors often worry about dilution, which means new shares reduce the ownership percentage of existing holders. That can weigh on a stock, especially when the raising is done at a discount. AoFrio (ASX:AOF) raised NZ$4.428 million to fund offshore growth. RemSense (ASX:REM) added $1.21 million in a heavily subscribed placement and the shares rose 9.09%, suggesting the market liked both the demand for the raise and the planned spend on its virtualplant platform. TZ Limited (ASX:TZL), Beonic (ASX:BEO) and Spenda (ASX:SPX) also stayed in funding mode, with investors watching closely for debt reduction, issue prices and how quickly the new money turns into simpler, stronger operations.

Operations mattered, but so did legal risk

StepChange Holdings (ASX:STH) said FY26 revenue should top $55 million with normalised EBITDA of $5 million and appointed a new chief operating officer. EBITDA is a rough measure of operating profit before interest, tax and some accounting charges. The stock still ended lower for the week, which points to only modest enthusiasm. EROAD (ASX:ERD) offered a more mixed picture. Revenue was stable, but a large North American write-down forced a regional reset. A write-down means the company judged those assets to be worth less than it once thought. Bailador Technology Investments (ASX:BTI) lifted the value of PropHero and MOSH, but wrote Nosto down to zero. That was a reminder that private tech valuations can move sharply in both directions. Elsewhere, legal and timing issues stayed in view. Credit Clear’s court battle with the ACCC was the clearest drag on sentiment because the final cost is unknown. Identitii (ASX:ID8) continued to fight JPMorgan’s bid for legal fees in a US patent case. Aspermont (ASX:ASP) pushed back the timing for sustainable operating cash inflow to the second half of FY27 after contract delays. In plain English, the company now expects to wait longer before the business regularly brings in more cash than it spends. That sort of delay can test investor patience, even without a capital raising.